Stock Analysis: Tonghua Golden-Horse Pharmaceutical Industry

Company: Tonghua Golden-Horse Pharmaceutical Industry Company Limited

Bloomberg ticker: 000766 SZ

Market cap: US$3,952m

Background: Tonghua Golden-Horse Pharmaceutical Industry Company Limited is a company focused on the development, production, and sale of pharmaceutical products. It specializes in both Traditional Chinese Medicine (TCM) and Western medicine, with a focus on oncology, rheumatology, and digestive health. It operates primarily in China.

World Class Benchmarking of Tonghua Golden-Horse Pharmaceutical Industry

• Profitable Growth rank of 7 was up compared to the prior period’s 8th rank.

• This is below average performance compared to 340 medium Health Care companies worldwide.

• Profitability rank of 7 was worse than its Growth rank of 6.

• Profitability rank of 7 was up compared to the prior period’s 8th rank.

• This is below average performance compared to peers.

• Growth rank of 6 was the same compared to the prior period’s 6th rank.

• This is below average performance compared to peers